Accepted manuscripts after editorial review will be sent for review after obtaining Copyright transfer form from authors. The manuscript will be reviewed by two subject experts in respective fields. The comments of the reviewers will be considered and the comments of the reviewers will be forwarded to the corresponding author for revision as per the reviewer’s suggestions and Journal’s manuscript preparation guidelines. In case of negative comments on any manuscript the Editor-In-Chief may or may not allot the manuscript to third reviewer. On the basis of his/her comments, Editor-In-Chief may consult with one or more members of Editorial Board and reject/accept a manuscript on second stage with proper justification. Before publication, the manuscript will be screened for grammar and technical parameters and the Galley proof will be prepared and sent to the authors for last time to identify corrections. After suggested corrections, the article is published with all relevant.
IJBDR currently do not have any Digital Archiving Policy.
Manuscripts submitted to International Journal of Biological and Drug Research (IJBDR) are reviewed Blind Peer Review process. The manuscript first undergoes Editorial Review to determine the eligibility and appropriateness of the manuscript as per the Journal’s scope. After finding the appropriateness of the manuscript, Editor-In-Chief will decide either to forward the manuscript for Review or reject with suitable justifications.
Accepted manuscripts after editorial review will be sent for review after obtaining Copyright transfer form from authors. The manuscript will be reviewed by two subject experts in respective fields. The comments of the reviewers will be considered and the comments of the reviewers will be forwarded to the corresponding author for revision as per the reviewer’s suggestions and Journal’s manuscript preparation guidelines. In case of negative comments on any manuscript the Editor-In-Chief may or may not allot the manuscript to third reviewer. On the basis of his/her comments, Editor-In-Chief may consult with one or more members of Editorial Board and reject/accept a manuscript on second stage with proper justification. Before publication, the manuscript will be screened for grammar and technical parameters and the Galley proof will be prepared and sent to the authors for last time to identify corrections. After suggested corrections, the article is published with all relevant inclusions like Page numbers, DOI etc.
Associate editor and review editors provide the administrative support to maintain the integrity of the peer review process. IJBDR follows strict and standard review and manuscript preparation guidelines.
IJBDR has adopted and follows the Publication Ethics and Malpractice guidelines.
Whereas Committee on Publication Ethics, COPE guidelines are followed for Publication Malpractice related issues like:
IJBDR are disseminated used for non commercial purposes with proper attribution and credit (citation) to the original writer. The Author holds the Copyrights for his/her work but he/she can not publish the published content in the same manner with other journals.In case of use of information available on IJBDR website, permission can be requested to the Editor-In-Chief by mailing at editor@ijbdr.com
All the authors willing to submit manuscript to the IJBDR must ensure the originality of the contents when drafting a manuscript.
Use of work/findings/information/results of other researchers must be properly cited at appropriate places within the manuscript. IJBDR uses Crossref Similarity Check software (i-Thenticate) to detect plagiarism. In case, plagiarism is detected during review/editorial process, such manuscripts will be rejected immediately.
If the plagiarism is proven after publication, such manuscript(s) will be retracted from the journal and appropriate announcement will be placed in this regards.
All the authors publishing in IJBDR are required to declare and disclose all the financial and possible conflicts of interest/competing interests they may have with the publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflicts of interest with products that compete with those mentioned in their manuscript.
Patients have a right to privacy, thus all the studies including humans should be conducted with informed consent. Publication should not contain any identifying information of the subjects in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. When informed consent has been obtained, it should be indicated in the article. Investigations with human subjects must follow the ethical standards formulated in the Helsinki Declaration of 1964, revised in 2008. All the experiment should be approved by the institutional human experimentation committee or equivalent.
Animal experiments must follow the ethical standards for the care and use of laboratory animals. Article involved the animal experiments must seek approval from the Institutional Ethical Committee in accordance with "Principles of Laboratory Animal Care" (NIH publication no. 85-23, revised 1985).
The authors are advised to register for the clinical trials with a clinical trial registry that allows free online access to public. Registration in the following trial registers is acceptable: Clinical Trial Registry India, Netherlands Trial Register, UMIN Japan, NHMRC Australia, USNLM, ISRCTN registry and other recognized institutions.
IJBDR does not offers any Article Processing Charge.
IJBDR is solely responsible for the content thereof IJBDR, Editor-In-Chief, its editorial board members, advisory members, publishers or anyone else involved in editing, pagination, producing or distribution assumes any liability for the accuracy, completeness, or usefulness of any information provided in the journal, nor shall they be liable for any direct, indirect, incidental, special, consequential, or punitive damages arising out of the use of IJBDR.